This proportion of PD-L1 positive disease is slightly higher than previous HNSCC cohorts analyzed in the literature where studies have demonstrated positivity rates between 57% and 82% [5,10,11]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.